The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
HealthCare Royalty and Blue Owl Announce $250M Debt Financing Partnership with TG Therapeutics
Aug 06, 2024•almost 2 years ago
Contract Type
partnership
ConnecticutBiotechnology
Description
HealthCare Royalty and Blue Owl Capital have entered into a $250 million term loan facility partnership with TG Therapeutics, Inc. This partnership provides TG Therapeutics with meaningful capital to support its business objectives.
Company Information
Company
HealthCare Royalty Partners (HCRx)
Location
Connecticut, United States
About
Founded in 2006, HCRx is a leading asset management firm focused on investments in commercial-stage and near-commercial-stage biopharmaceutical assets. It has a strong track record of performance, having deployed over $7 billion in capital. The firm manages approximately $3 billion in assets across diverse therapeutic areas. HCRx offers structured financing solutions for biopharma companies.
Predictive Intelligence
Strategic
ML-powered predictions for HealthCare Royalty Partners (HCRx)'s next move
ConnecticutBiotechnology